# Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury

> **NCT01627613** · PHASE2 · COMPLETED · sponsor: **Apeptico Forschung und Entwicklung GmbH** · enrollment: 40 (actual)

## Conditions studied

- Acute Lung Injury

## Interventions

- **DRUG:** AP301
- **DRUG:** Saline solution

## Key facts

- **NCT ID:** NCT01627613
- **Lead sponsor:** Apeptico Forschung und Entwicklung GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-05
- **Final completion:** 2014-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01627613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01627613, "Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01627613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*